ZDHHC9 and breast cancer: These results suggest that high expression of ZDHHC9 is associated with an immunosuppressive microenvironment and that ZDHHC9 can serve as an important marker for guiding the classification, diagnosis and prognosis of breast cancer, including TNBC, and developing specific targeted therapies.